We are live on ! Find out more
ASMB icon

Assembly Biosciences
ASMB

98 hedge funds and large institutions have $703M invested in Assembly Biosciences in 2017 Q4 according to their latest regulatory filings, with 37 funds opening new positions, 37 increasing their positions, 19 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

236% more first-time investments, than exits

New positions opened: 37 | Existing positions closed: 11

95% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 19

63% more capital invested

Capital invested by funds: $432M → $703M (+$271M)

36% more funds holding

Funds holding: 72 → 98 (+26)

12% more call options, than puts

Call options by funds: $5.62M | Put options by funds: $5.03M

0.56% more ownership

Funds ownership: 5.94% → 6.5% (+0.56%)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

Holders
98
Holders Change
+26
Holders Change %
+36.11%
% of All Funds
2.22%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
37
Increased
37
Reduced
19
Closed
11
Calls
$5.62M
Puts
$5.03M
Net Calls
+$589K
Net Calls Change
+$2.45M

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$17M
2
Jennison Associates
Jennison Associates
New York
+$13.1M
3
FCM
Farallon Capital Management
California
+$9.43M
4
Invesco
Invesco
Georgia
+$9.29M
5
EA
Emerald Advisers
Pennsylvania
+$7.23M

Top Sellers

Rank Fund Capital Flow
1
VFA
Valeo Financial Advisors
Indiana
-$4.96M
2
QF
QVT Financial
New York
-$1.86M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.69M
4
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$990K
5
LSC
Lyon Street Capital
California
-$905K
Name Holding Trade Value Shares
Change 		Change in
Stake
Mackenzie Financial
51
Mackenzie Financial
Ontario, Canada
$748K – – –
New York State Common Retirement Fund
52
New York State Common Retirement Fund
New York
$679K – – –
CS
53
Credit Suisse
Switzerland
$628K +$116K +257 +29%
JGGDR
54
JGP Global Gestao de Recursos
Brazil
$597K -$52.5K -116 -10%
RhumbLine Advisers
55
RhumbLine Advisers
Massachusetts
$581K -$79.2K -175 -14%
Citadel Advisors
56
Citadel Advisors
Florida
$569K +$475K +1,049 New
Manulife (Manufacturers Life Insurance)
57
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$560K +$50.7K +112 +12%
Simplex Trading
58
Simplex Trading
Illinois
$558K +$195K +430 +72%
NI
59
Numeric Investors
Massachusetts
$557K +$464K +1,025 New
AllianceBernstein
60
AllianceBernstein
Tennessee
$543K +$453K +1,000 New
State of Wisconsin Investment Board
61
State of Wisconsin Investment Board
Wisconsin
$498K – – –
AIG
62
American International Group
New York
$491K +$54.3K +120 +15%
PPA
63
Parametric Portfolio Associates
Washington
$489K +$17.7K +39 +5%
State Board of Administration of Florida Retirement System
64
State Board of Administration of Florida Retirement System
Florida
$445K -$39.8K -88 -10%
ECM
65
Endurant Capital Management
California
$430K +$359K +792 New
Commonwealth Equity Services
66
Commonwealth Equity Services
Massachusetts
$415K +$346K +765 New
Squarepoint
67
Squarepoint
New York
$376K +$313K +692 New
Wells Fargo
68
Wells Fargo
California
$367K -$660K -1,458 -68%
VFA
69
Virtus Fund Advisers
Connecticut
$361K +$301K +665 New
Goldman Sachs
70
Goldman Sachs
New York
$346K -$148K -327 -34%
MIM
71
MetLife Investment Management
New Jersey
$326K +$272K +600 New
GCP
72
GSA Capital Partners
United Kingdom
$322K +$268K +592 New
VOYA Investment Management
73
VOYA Investment Management
Georgia
$315K +$17.2K +38 +7%
William Blair & Company
74
William Blair & Company
Illinois
$312K +$260K +575 New
MWNA
75
Marshall Wace North America
New York
$273K +$228K +503 New
1 2
3
4 5

ASMB Hedge Fund Activity: Q4 2017 in Review

98 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Assembly Biosciences (ASMB) for Q4 2017, worth a combined $703M — up 63% from $432M a quarter earlier.

Buyers outnumbered sellers: 37 funds opened new ASMB positions and 11 closed out — a net gain of 26 holders — while 37 added to existing stakes and 19 trimmed.

The largest buyer was OrbiMed, adding an estimated $17M. The largest seller was Valeo Financial Advisors, exiting entirely with an estimated $4.96M sold.

  • 98 institutional investors held Assembly Biosciences (ASMB) as of Q4 2017, up from 72 in Q3 2017.
  • Funds reported $703M of Assembly Biosciences stock for Q4 2017, up 63% quarter-over-quarter.
  • 37 funds opened new Assembly Biosciences positions in Q4 2017 and 11 closed out, a net change of +26 holders.
  • The largest Assembly Biosciences buyer in Q4 2017 was OrbiMed, an estimated $17M added.
  • The largest Assembly Biosciences seller in Q4 2017 was Valeo Financial Advisors, an estimated $4.96M sold.

Based on aggregated 13F filings for Q4 2017.